AASM News Archive

Study suggests that zaleplon does not aid CPAP adherence A new study suggests that a single dose of zaleplon at the start of CPAP titration during split-night polysomnography does not result in superior CPAP adherence or improved symptoms at one month. Published in the May 15 issue of the Journal of Clinical Sleep Medicine, the study involved 134 patients newly diagnosed with obstructive sleep apnea.

Study links sleep apnea to risk of developing depression A study in the May 15 issue of the Journal of Clinical Sleep Medicine reports that people with obstructive sleep apnea have a higher risk of developing depressive disorder. Participants with OSA were two times more likely than those without OSA to develop depressive disorder within a year (hazard ratio = 2.18).

FDA advisory panel recommends approval of suvorexant for insomnia On Wednesday, May 22, the FDA Peripheral and Central Nervous System Drugs Advisory Committee discussed a new drug application for suvorexant tablets (NDA #204569), which was submitted by Merck Sharp and Dohme Corp., Worldwide Regulatory Group.

Survey finds most employers plan to keep full-time workers' health benefits According to an International Foundation of Employee Benefit Plans survey, most employers expect to continue providing full-time workers with health insurance benefits after the Affordable Care Act is fully implemented.

More physicians adopting new business models, practice techniques because of changing health care system Kaiser Health News reports that more doctors are experimenting with new business models and practice techniques as they face falling reimbursement rates and rising demands from the federal government and insurers to boost quality and lower costs.